Core Viewpoint - Xuan Zhu Bio-B (02575) has successfully completed its global offering, raising approximately HKD 701 million through the issuance of H-shares at a price of HKD 11.6 per share [1] Summary by Category Offering Details - The company issued a total of 67.33 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - Each board lot consists of 500 shares, and trading is expected to commence on October 15, 2025, at 9:00 AM Hong Kong time [1] Subscription Demand - The Hong Kong public offering was oversubscribed by 4,908.33 times, indicating strong local investor interest [1] - The international offering saw a subscription rate of 10.15 times, reflecting robust demand from global investors [1]
轩竹生物-B(02575)：每股发售价11.6港元 香港公开发售获4908.33倍认购